Experimental titanium alloys for dental applications.
Although the use of titanium has increased, casting difficulties limit routine use. The purpose of the present study was to compare the mechanical properties and biocompatibility of the experimental titanium alloys titanium-5-zirconium, titanium-5-tantalum, and titanium-5-tantalum-5-zirconium (in wt%) with those of commercially pure titanium. Specimens of titanium alloys and commercially pure titanium were cast by using plasma. Their modulus of elasticity and ultimate tensile strength were determined in a universal testing machine. Biocompatibility was evaluated with SCC9 cells. In periods of 1, 4, 7, 10, and 14 days, cell proliferation was evaluated by the (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) tetrazolium reduction assay, and cell viability was evaluated in the 7-day period. Cell morphology was evaluated at 2, 12, and 24 hours. Modulus of elasticity, ultimate tensile strength, and cell viability were analyzed by 1-way ANOVA and the Bonferroni test; cell proliferation data were compared by 2-way ANOVA (alloy versus time) and by the Bonferroni test; and the cell morphology data were analyzed by split-plot design. All statistical tests were performed at the 95% confidence level (P<.05). Titanium-5-tantalum presented the lowest modulus of elasticity and ultimate tensile strength, whereas titanium-5-zirconium and titanium-5-tantalum-5-zirconium were statistically similar to commercially pure titanium. Cell proliferation and viability were not affected by any alloy being similar to those observed for commercially pure titanium. No noticeably differences were found in the morphology of cells cultured on any alloy and commercially pure titanium. Experimental alloys, especially titanium-5-zirconium and titanium-5-tantalum-5-zirconium, presented promising mechanical results for future studies and clinical applications. In addition, these alloys, evaluated by cell proliferation, viability, and morphology, were found to be biocompatible in vitro.